Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Loading
Home›
Research›
Investment Firms›
Adams Street Partners
AddedFeb 13, 2024
UpdatedJul 22, 2026
Adams Street Partners

Adams Street Partners

Operating

Adams Street Partners: A globally respected private markets investment manager.

Location
Chicago, IL, US
Founded
1972
Firm
Analysis
Compare
Portfolio
Employees
News
Website

Investments

Turquoise Health
Turquoise Health

Total Raised

$55.3M

Rounds

4

Series B$30MJanuary 2024
Altruist
Altruist
Series E

Total Raised

$449.5M

Rounds

6

Series D$112MApril 2023
BillionToOne
BillionToOne
Debt

Total Raised

$295.9M

Rounds

7

Series C$48.5MDecember 2022
Series C$125MMarch 2022
DispatchHealth
DispatchHealth

Total Raised

$733.2M

Rounds

7

Series E$330MNovember 2022
ClassDojo
ClassDojo

Total Raised

$191.1M

Rounds

5

Series D$125MJuly 2022
Nomad Health
Nomad Health

Total Raised

$218M

Rounds

9

Series Unknown$105MJune 2022
Series D$63MSeptember 2021
FalconX
FalconX

Total Raised

$477M

Rounds

8

Series D$150MJune 2022
Reify Health
Reify Health

Total Raised

$479.6M

Rounds

7

Series D$220MApril 2022
Series C$220MAugust 2021
Remote
Remote

Total Raised

$496M

Rounds

4

Series C$300MApril 2022
Dremio
Dremio

Total Raised

$410M

Rounds

6

Series E$160MJanuary 2022
Orca Security
Orca Security

Total Raised

$632M

Rounds

5

Series C$340MOctober 2021
Iterable
Iterable

Total Raised

$342.2M

Rounds

7

Series E$200MJune 2021
Homeward
Homeward

Total Raised

$501M

Rounds

6

Series B$136MMay 2021
Actium Health
Actium Health

Total Raised

$35M

Rounds

2

Series B$25MMay 2021
ThreatQuotient
ThreatQuotient

Total Raised

$87.6M

Rounds

9

Debt Financing$9.5MApril 2021
Series Unknown$13MApril 2021
Redox
Redox

Total Raised

$95M

Rounds

8

Series D$45MFebruary 2021
Freeman Spogli
Freeman Spogli

Rounds

1

—December 2020
Lyra Health
Lyra Health

Total Raised

$910.1M

Rounds

8

Series D$110MAugust 2020
Robinhood
Robinhood
Public

Total Raised

$6.2B

Rounds

25

Series F$320MJuly 2020
Palvella Therapeutics
Palvella Therapeutics
Acquired

Total Raised

$106.8M

Rounds

6

Series C$45MMay 2020
Couchbase
Couchbase
Public

Total Raised

$251M

Rounds

10

Series G$105MMay 2020